Artificial intelligence and medicine: Mounting risks amid the promise
Cancer Cytopathology · 2023
DOI: 10.1002/cncy.22739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, 2023. Verfasst von Bryn Nelson und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Medicine, Biomedical Research. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. In this second of a two‐part series, developers have touted artificial intelligence as a boon for both medical research and clinical applications, but plenty of pitfalls are giving ethicists and other experts considerable pause in their use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Nelson, B., & Faquin, W. (2023). Artificial intelligence and medicine: Mounting risks amid the promise. Cancer Cytopathology. https://doi.org/10.1002/cncy.22739
Vancouver
Nelson B, Faquin W. Artificial intelligence and medicine: Mounting risks amid the promise. Cancer Cytopathology. 2023. doi:10.1002/cncy.22739
BibTeX
@article{Nelson2023,
author = {Nelson, Bryn and Faquin, William},
title = {Artificial intelligence and medicine: Mounting risks amid the promise},
journal = {Cancer Cytopathology},
year = {2023},
doi = {10.1002/cncy.22739}
}
EUVIMED